- Home
- CAF vs OSUR Comparison
CAF vs OSUR Comparison
Compare CAF & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAF
- OSUR
- Stock Information
- Founded
- CAF 2006
- OSUR 2000
- Country
- CAF United States
- OSUR United States
- Employees
- CAF N/A
- OSUR N/A
- Industry
- CAF Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- CAF Finance
- OSUR Health Care
- Exchange
- CAF Nasdaq
- OSUR Nasdaq
- Market Cap
- CAF 218.7M
- OSUR 223.0M
- IPO Year
- CAF N/A
- OSUR 1986
- Fundamental
- Price
- CAF $13.19
- OSUR $2.65
- Analyst Decision
- CAF
- OSUR Hold
- Analyst Count
- CAF 0
- OSUR 2
- Target Price
- CAF N/A
- OSUR $5.50
- AVG Volume (30 Days)
- CAF 63.6K
- OSUR 460.4K
- Earning Date
- CAF 01-01-0001
- OSUR 05-07-2025
- Dividend Yield
- CAF 1.02%
- OSUR N/A
- EPS Growth
- CAF N/A
- OSUR N/A
- EPS
- CAF N/A
- OSUR N/A
- Revenue
- CAF N/A
- OSUR $161,626,000.00
- Revenue This Year
- CAF N/A
- OSUR N/A
- Revenue Next Year
- CAF N/A
- OSUR $7.55
- P/E Ratio
- CAF N/A
- OSUR N/A
- Revenue Growth
- CAF N/A
- OSUR N/A
- 52 Week Low
- CAF $11.63
- OSUR $2.69
- 52 Week High
- CAF $14.38
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- CAF 63.83
- OSUR 36.68
- Support Level
- CAF $12.60
- OSUR $2.42
- Resistance Level
- CAF $13.24
- OSUR $2.76
- Average True Range (ATR)
- CAF 0.18
- OSUR 0.11
- MACD
- CAF 0.06
- OSUR -0.02
- Stochastic Oscillator
- CAF 93.75
- OSUR 34.33
About CAF Morgan Stanley China A Share Fund Inc.
Morgan Stanley China A Share Fund Inc is the United States based non-diversified, closed-end management investment company. Its investment objective is to seek capital growth by investing a majority of its assets in A-shares of Chinese companies listed on the Shanghai and Shenzhen Stock Exchanges. Its portfolio of investments consists of investment in different sectors such as the aerospace and defense, banks, automobiles, household durables, media, pharmaceuticals, software and other sectors.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.